Understanding autoimmune pancreatitis worldwide. Read more about Understanding autoimmune pancreatitis worldwide.
The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice. Read more about The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice.
The diagnostic approach to monogenic very early onset inflammatory bowel disease. Read more about The diagnostic approach to monogenic very early onset inflammatory bowel disease.
Insights into the molecular pathophysiology of inflammatory bowel disease: ATG16L1 suppresses nod-driven inflammation. Read more about Insights into the molecular pathophysiology of inflammatory bowel disease: ATG16L1 suppresses nod-driven inflammation.
CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer. Read more about CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
The intestinal metabolome: an intersection between microbiota and host. Read more about The intestinal metabolome: an intersection between microbiota and host.
A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice. Read more about A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.
Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. Read more about Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease.
American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Read more about American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease. Read more about Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
